Advanced in Penile Cancer

Giuliano B. Guglielmetti

University Of Sao Paulo Medical School And Institute Of Cancer Estate Of Sao Paulo, 
Sao Paulo, SP, BR 
Advanced in Penile Cancer
University Of Sao Paulo Medical School And Institute Of Cancer Estate Of Sao Paulo, 
Sao Paulo, SP, BR 
OverviewLocationsClinical Research

Overview

Giuliano Guglielmetti practices in Sao Paulo, Brazil. Mr. Guglielmetti is rated as an Advanced expert by MediFind in the treatment of Penile Cancer. His top areas of expertise are Penile Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Lymphadenectomy, and Nephrectomy.

His clinical research consists of co-authoring 45 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Penile Cancer.

Gender
Male

Locations

University Of Sao Paulo Medical School And Institute Of Cancer Estate Of Sao Paulo, Sao Paulo, SP, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase II Study of Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for Patients With High-Risk Localized Prostate Cancer Prior to Radical Prostatectomy
Phase II Study of Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for Patients With High-Risk Localized Prostate Cancer Prior to Radical Prostatectomy
Enrollment Status: Completed
Publish Date: September 15, 2022
Intervention Type: Drug
Study Drugs: Goserelin, Prednisone, Abiraterone, Apalutamide
Study Phase: Phase 2

45 Total Publications

Multiparametric MRI combined with PSA density as a noninvasive rule-out strategy in active surveillance for prostate cancer.
Multiparametric MRI combined with PSA density as a noninvasive rule-out strategy in active surveillance for prostate cancer.
Journal: BJUI compass
Published: June 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Guglielmetti's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile